Taclonex Topical Suspension Recalled for Outdated Package Insert
LEO Pharma Inc. is recalling Taclonex topical suspension because it was packaged with an out-of-date package insert.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The issue is a documentation/packaging error (outdated insert) rather than a product defect.
Plain-English summary
LEO Pharma Inc. is recalling Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%. The affected product is packaged in 60 g and 120 g tubes and is a prescription-only medication. The recall involves 189,610 units distributed nationwide within the US.
The recall was initiated because the affected product was packaged with an out-of-date package insert (PI) dated February 2014. This is a labeling issue regarding the documentation provided with the medication.
Consumers and healthcare providers should check their inventory for the specific lot numbers listed in the recall notice. If the product matches the recalled lots, it should be returned to the pharmacy or supplier for replacement or refund.
The recalled product
- Product
- TACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)
- Brand
- TACLONEX
- Manufacturer
- LEO PHARMA INC
- Category
- Drug — Topical Prescription
- Hazard
- Affected units
- 189,610
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: (a): EK9025
- Exp. 2/28/2017
- EL1057
- Exp. 3/31/2017
- EL4637
- Exp. 6/30/2017
- EM0825B
- Exp. 11/30/2017
- EM3992
- Exp. 1/31/2019
- A22902
- Exp. 5/31/2019
- A31838
- Exp. 9/30/2019 Lot #:EK7007A
- EK7007AA
- Exp. 1/31/2017
- EL2024
- EL2979
- Exp. 5/31/2017
- EL8069
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · LEO PHARMA INC
See all →- HighADBRY Injection Drug Recall for Particulate Contamination
FDA (Drugs) · 2026-03-04
- ModerateLEO Pharma Recalls Calcipotriene Cream Due to Labeling Errors
FDA (Drugs) · 2017-03-15
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02